We're relying on you to nominate the trailblazing thought leaders, opinion shapers and unsung heroes of pathology that you want to see on the list!
Liquid biopsy can help us appropriately treat patients with anti-PD-L1 immunotherapies, and ddPCR enables ongoing monitoring and adjustment of treatment
An efficient alternative to pap-HPV tests could lie with ddPCR and a ccfDNA assay
Antonia R. Sepulveda
New collaborative guidelines for molecular biomarker testing in colorectal cancer
An examination of domain-specific companion diagnostic testing
An industry pathologist’s perspective on developing a companion diagnostic
Henrik Winther and Hans Christian Pedersen
Industry and regulators collaborate to harmonize or consolidate PD-1/PDL-1 assays
How liquid biopsy and next-generation sequencing fit into the pathology lab of the future
Anthony Whetton, Director of the Stoller Biomarker Discovery Centre, Manchester, UK
FDA issues first-ever approval for liquid biopsy companion diagnostic
Digital pathology and tissue image analysis tools are essential to developing companion diagnostics and enabling pathologists to support clinical decisions, but there is still work to be done…
Send me the latest from The Pathologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.